Sanofi Names Montpellier Global Hub for Autoimmune Disease Research
Sanofi, in partnership with the Immun4Cure University Hospital Institute in Montpellier, has launched a Translational Centre of Excellence focused on developing treatments for autoimmune and inflammatory diseases. The centre aims to place patients at the core of R&D, spanning early research through advanced clinical trials.
Artificial Intelligence | 16/10/2025 | By Dineshwori | 107
CPHI Frankfurt 2025: Marchesini Group to Showcase High-Speed AI-Powered Inspection Machine
Marchesini Group, a global leader in the development of complete lines for packaging and filling pharmaceutical and cosmetic products, will showcase a range of inspection, digitalisation, and laboratory innovations at CPHI Frankfurt 2025, taking place from October 28–30.
Artificial Intelligence | 15/10/2025 | By Dineshwori | 178
New manufacturing facility to be located near Charlottesville, in Albemarle County, Virginia will develop and manufacture a broader range of medicines including weight management, metabolic and cancer technologies.<br />
Artificial Intelligence | 10/10/2025 | By Dineshwori
Roche receives CE Mark for AI-based Kidney Klinrisk Algorithm
The new CKD algorithm panel, available on the Navify Algorithm Suite, marks a step in Roche’s strategy to provide digital health solutions for the growing global burden of CKD.
Artificial Intelligence | 07/10/2025 | By Dineshwori | 181
Mstack launches R&D platform Chemstack AI
Mstack's rapid expansion reflects extraordinary market demand for supply chain diversification, scaling to over 100 enterprise customers across North America, India, China and the Middle East, with over 100 employees spanning data science, AI, technology development, R&D, operations, and sales.
Artificial Intelligence | 30/09/2025 | By Dineshwori | 150
GlobalData's AI Tool Predicts Pharmaceutical Drug Approvals with 85 Percent Success Rate
GlobalData’s enhanced AI-powered Likelihood of Approval (LoA) model boosts its predictive power, providing probability of a drug receiving market authorisation.
Artificial Intelligence | 29/09/2025 | By Dineshwori
Lilly Plans to Build USD 6.5 Billion Facility to Manufacture APIs in Texas
Eli Lilly will invest USD 6.5 billion to set up a new API manufacturing facility in Houston, Texas—its eighth US site since 2020—creating over 4,600 jobs and boosting domestic production of small molecule medicines.
Artificial Intelligence | 24/09/2025 | By Dineshwori | 111
Vincerx Pharma Signs Non-Binding LOI for Business Combination with QumulusAI
Under the proposed terms, a subsidiary of Vincerx would merge into QumulusAI, with QumulusAI stockholders receiving shares of Vincerx common stock.
Artificial Intelligence | 21/03/2025 | By Aishwarya | 295
Clario Acquires ArtiQ to Boost AI Use in Clinical Trials
Clario has recently acquired ArtiQ, an innovative software company dedicated to enhancing the diagnosis and monitoring of patients with respiratory conditions.
Artificial Intelligence | 05/04/2024 | By Aishwarya | 679
AI and ML devices transforming healthcare
AI and ML in medical devices transform healthcare aiding diagnosis accuracy: Koji Wada
Artificial Intelligence | 19/04/2022 | By Sudeep Soparkar | 644
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy